Cite
Outcomes for potentially Resectable patients undergoing primary chemoradiation treatment for T1–T2 HPV Negative oropharyngeal squamous cell carcinoma.
MLA
Laxague, Francisco, et al. “Outcomes for Potentially Resectable Patients Undergoing Primary Chemoradiation Treatment for T1–T2 HPV Negative Oropharyngeal Squamous Cell Carcinoma.” Head & Neck, vol. 46, no. 11, Nov. 2024, pp. 2789–97. EBSCOhost, https://doi.org/10.1002/hed.27802.
APA
Laxague, F., Fnais, N., Son, H. Y., Alzahrani, F., Mymryk, J. S., Barrett, J. W., Tay, K. Y., Leung, A., Theurer, J., Nichols, A. C., & Palma, D. A. (2024). Outcomes for potentially Resectable patients undergoing primary chemoradiation treatment for T1–T2 HPV Negative oropharyngeal squamous cell carcinoma. Head & Neck, 46(11), 2789–2797. https://doi.org/10.1002/hed.27802
Chicago
Laxague, Francisco, Naif Fnais, Hee Young Son, Faisal Alzahrani, Joe S. Mymryk, John W. Barrett, Keng Yow Tay, et al. 2024. “Outcomes for Potentially Resectable Patients Undergoing Primary Chemoradiation Treatment for T1–T2 HPV Negative Oropharyngeal Squamous Cell Carcinoma.” Head & Neck 46 (11): 2789–97. doi:10.1002/hed.27802.